Business Insider: Inside the internet's underground fertility drug trade
UC fertility expert discusses hazards of purchasing fertility drugs via internet
In vitro fertilization drugs are expansive and only 13 states mandate insurance coverage in this area. Even when patients are insured, essential in vitro fertilization drugs, which can cost up to $5,000 per round, are often excluded. Just as patients overcome biological hurdles to parenthood, they need to clear financial ones as well. That has led to a booming underground drug trade on Instagram.
Suruchi Thakore, MD, an assistant professor of obstetrics and gynecology at UC, warns that patients who source their own drugs may compromise their own fertility treatment. Medications from unconventional sources, whether it’s a neighbor, Instagram follower, or overseas pharmacy are more likely to have been improperly stored. And that can lower their effectiveness, Thakore, a UC Health physician, told Insider.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.